Reports

Sale

Australia and New Zealand Ultrasound Devices Market

Australia and New Zealand Ultrasound Devices Market Size: By Type: Stationary Ultrasound, Portable Ultrasound; By Technology: 2D Ultrasound Imaging, 3D and 4D Ultrasound Imaging, Doppler Imaging, High-intensity Focused Ultrasound; By Applications; By Portability; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Australia and New Zealand Ultrasound Devices Market Outlook

The Australia and New Zealand ultrasound devices market size is anticipated to grow at a CAGR of 6.07% during the forecast period of 2024-2032, driven by the increasing prevalence of cardiovascular diseases across the globe.

 

Australia and New Zealand Ultrasound Devices Market Overview

The growth of the market  is being driven by the advancements in medical technology and increasing healthcare awareness. This dynamic market is witnessing a rising demand for cutting-edge ultrasound devices, including portable and 3D/4D imaging systems. The regions’ healthcare infrastructure development, coupled with a growing elderly population, contributes to the expanding market. Additionally, the emphasis on early disease detection and prenatal care fuels the adoption of ultrasound technology. The Australia and New Zealand ultrasound devices market growth is also driven by the growing burden of chronic diseases, like cardiovascular diseases and cancer, along with increased healthcare investments and technological advancements.

 

According to According to the cancer data in Australia, there were approximately 3,830 new cases of thyroid cancer diagnosed in Australia, with 1,070 cases in males and 2,760 in females. The report also indicates that the likelihood of being diagnosed with thyroid cancer by the age of 85 is projected to be 1 in 83 (1.2%), with specific probabilities for males (1 in 145 or 0.69%) and females (1 in 58 or 1.7%). Ultrasound, being a convenient and widely available imaging modality that does not involve ionizing radiation, is considered ideal for detecting and evaluating thyroid nodules. Consequently, the increasing incidence of thyroid cancer in the country is expected to drive the Australia and New Zealand ultrasound devices market demand.

 

Increasing Funding by the Government Strengthens Imaging Services

The Australian Government's augmented financial support for enhancing imaging services is anticipated to fuel the market expansion. The government  allocated additional funds for the expansion of the Heart of Australia Program in April 2022, amounting to approximately USD 12.0 million. This program extends mobile medical clinic services throughout northern Queensland, offering heart monitoring and various healthcare services. The government's commitment to cardiovascular care delivery is expected to boost the demand for ultrasound equipment, contributing to the Australia and New Zealand ultrasound devices market share.

 

Increasing Usage of High-intensity Focused Ultrasound Source

High-intensity focused ultrasound is increasingly employed in the treatment of both primary and metastatic tumors due to its precise tumor identification capabilities during ablation. In cases where patients exhibit substantial medical co-morbidities, rendering them high-risk candidates for surgery, or possess lower liver function restricting hepatectomy, high-intensity focused ultrasound emerges as a viable therapeutic option for addressing liver tumors. High-intensity focused ultrasound emerges as a promising and safe alternative for the minimally invasive treatment of localized prostate cancer.

 

Notably, recent research published by the Mayo  Foundation in August underscores the growing interest in mitigating treatment-related side effects associated with prostate cancer by targeting a specific portion of the affected prostate. Focal therapy, utilizing high-intensity focused ultrasound (HIFU), proves effective in addressing this concern. HIFU precisely targets the most aggressive tumor, sparing the surrounding prostate structures. This approach is widely accepted in treating various cancers, including kidney cancers, where only the tumor is removed or ablated, leaving the rest of the organ intact. Consequently, the increased demand for HIFU systems may drive their adoption in Australian healthcare for minimally invasive prostate cancer treatment.

 

Australia and New Zealand Ultrasound Devices Market Segmentations

Market Breakup by Type

  • Stationary Ultrasound
  • Portable Ultrasound

 

Market Breakup by Technology

  • Advanced2D Ultrasound Imaging
  • 3D and 4D Ultrasound Imaging
  • Doppler Imaging
  • High-intensity Focused Ultrasound

 

Market Breakup by Applications

  • Anesthesiology
  • Cardiology
  • Gynecology/Obstetrics
  • Musculoskeletal
  • Radiology
  • Primary Care
  • Critical Care
  • Emergency Medicine

 

Market Breakup by Portability

  • Handheld
  • Compact
  • Cart/Trolley
    • Point-of-Care Cart/Trolley Based Ultrasound
    • Higher-end Cart/Trolley Based Ultrasound

 

Market Breakup by End User

  • Hospitals
  • Imaging Centres
  • Research Centres

 

Market Breakup by Country

  • Australia
  • New Zealand

 

Australia and New Zealand Ultrasound Devices Market: Competitor Landscape

The ultrasound devices market in Australia and New Zealand exhibits a moderate level of competitiveness, with prominent players. Key market leaders include Mindray Medical International Limited, Siemens Healthineers AG, GE Healthcare, Fujifilm Holdings Corporation, and Koninklijke Philips NV, among others.

 

In November 2022, Caption  Health disclosed the receipt of regulatory approvals from Health Canada's Medical Devices Directorate and Australia's Therapeutic Goods Administration to market its Caption AI technology platform. This innovative platform enables healthcare professionals in Australia and Canada, regardless of prior sonography experience, to conduct cardiac ultrasounds.

 

The key features of the Australia and New Zealand ultrasound devices market report includes patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

 

The major companies in the market are as follows:

  • Canon Medical Systems Corporation
  • SonoScape Medical Corp
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Samsung Electronics Co. Ltd.
  • Esaote SPA
  • Siemens Healthineers AG
  • ALPINION MEDICAL SYSTEMS Co., Ltd.
  • CHISON Medical Technologies Co., Ltd.
  • SAMSUNG HEALTHCARE
  • Analogic Corporation
  • General Electric

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Technology
  • Applications
  • Portability
  • End User
  • Region
Breakup by Type
  • Stationary Ultrasound
  • Portable Ultrasound
Breakup by Technology
  • 2D Ultrasound Imaging
  • 3D and 4D Ultrasound Imaging
  • Doppler Imaging
  • High-intensity Focused Ultrasound
Breakup by Applications
  • Anesthesiology
  • Cardiology
  • Gynecology/Obstetrics
  • Musculoskeletal
  • Radiology
  • Primary Care
  • Critical Care
  • Emergency Medicine
Breakup by Portability
  • Handheld
  • Compact
  • Cart/Trolley
Breakup by End User
  • Hospitals 
  • Imaging Centres
  • Research Centres
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Canon Medical Systems Corporation
  • SonoScape Medical Corp
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Samsung Electronics Co. Ltd.
  • Esaote SPA
  • Siemens Healthineers AG
  • ALPINION MEDICAL SYSTEMS Co., Ltd.
  • CHISON Medical Technologies Co., Ltd.
  • SAMSUNG HEALTHCARE
  • Analogic Corporation
  • General Electric

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Australia and New Zealand Ultrasound Devices Market Overview
 
    3.1    Australia and New Zealand Ultrasound Devices Market Historical Value (2017-2023) 
    3.2    Australia and New Zealand Ultrasound Devices Market Forecast Value (2024-2032)
4    Australia and New Zealand Ultrasound Devices Market Dynamics
    4.1    Market Drivers and Constraints
    4.2    SWOT Analysis
    4.3    Porter’s Five Forces Model 
    4.4    Key Demand Indicators
    4.5    Key Price Indicators
    4.6    Industry Events, Initiatives, and Trends 
    4.7    Value Chain Analysis
5    Australia and New Zealand Ultrasound Devices Market Segmentation 
    5.1    Australia and New Zealand Ultrasound Devices Market by Type
        5.1.1    Market Overview                                                             
        5.1.2    Stationary Ultrasound
        5.1.3    Portable Ultrasound
    5.2    Australia and New Zealand Ultrasound Devices Market by Technology
        5.2.1    Market Overview
        5.2.2    2D Ultrasound Imaging
        5.2.3    3D and 4D Ultrasound Imaging
        5.2.4    Doppler Imaging
        5.2.5    High-intensity Focused Ultrasound
    5.3    Australia and New Zealand Ultrasound Devices Market by Applications
        5.3.1    Market Overview
        5.3.2    Anesthesiology
        5.3.3    Cardiology
        5.3.4    Gynecology/Obstetrics
        5.3.5    Musculoskeletal
        5.3.6    Radiology
        5.3.7    Primary Care
        5.3.8    Critical Care
        5.3.9    Emergency Medicine
    5.4    Australia and New Zealand Ultrasound Devices Market by Portability
        5.4.1    Market Overview
        5.4.2    Handheld
        5.4.3    Compact
        5.4.4    Cart/Trolley
            5.4.4.1    Point-of-Care Cart/Trolley Based Ultrasound
            5.4.4.2    Higher-end Cart/Trolley Based Ultrasound
    5.5    Australia and New Zealand Ultrasound Devices Market by End User
        5.5.1    Market Overview
        5.5.2    Hospitals 
        5.5.3    Imaging Centres
        5.5.4    Research Centres
    5.6    Australia and New Zealand Ultrasound Devices Market by Country
        5.6.1    Market Overview
        5.6.2    Australia
        5.6.3    New Zealand 
6    Patent Analysis
    6.1    Analysis by Type of Patent
    6.2    Analysis by Publication year
    6.3    Analysis by Issuing Authority
    6.4    Analysis by Patent Age
    6.5    Analysis by CPC Analysis
    6.6    Analysis by Patent Valuation 
    6.7    Analysis by Key Players
7    Grants Analysis
    7.1    Analysis by year
    7.2    Analysis by Amount Awarded
    7.3    Analysis by Issuing Authority
    7.4    Analysis by Grant Application
    7.5    Analysis by Funding Institute
    7.6    Analysis by NIH Departments
    7.7    Analysis by Recipient Organization
8    Funding Analysis
    8.1    Analysis by Funding Instances
    8.2    Analysis by Type of Funding
    8.3    Analysis by Funding Amount
    8.4    Analysis by Leading Players
    8.5    Analysis by Leading Investors
    8.6    Analysis by Geography
9    Partnership and Collaborations Analysis
    9.1    Analysis by Partnership Instances
    9.2    Analysis by Type of Partnership
    9.3    Analysis by Leading Players
    9.4    Analysis by Geography
10    Regulatory Framework
    10.1    Regulatory Overview
11    Supplier Landscape
    11.1    Canon Medical Systems Corporation
        11.1.1    Financial Analysis
        11.1.2    Product Portfolio
        11.1.3    Demographic Reach and Achievements
        11.1.4    Mergers and Acquisitions
        11.1.5    Certifications
    11.2    SonoScape Medical Corp
        11.2.1    Financial Analysis
        11.2.2    Product Portfolio
        11.2.3    Demographic Reach and Achievements
        11.2.4    Mergers and Acquisitions
        11.2.5    Certifications
    11.3    Fujifilm Holdings Corporation
        11.3.1    Financial Analysis
        11.3.2    Product Portfolio
        11.3.3    Demographic Reach and Achievements
        11.3.4    Mergers and Acquisitions
        11.3.5    Certifications
    11.4    GE Healthcare
        11.4.1    Financial Analysis
        11.4.2    Financial Portfolio
        11.4.3    Demographic Reach and Achievements
        11.4.4    Mergers and Acquisitions
        11.4.5    Certifications
    11.5    Hologic Inc.
        11.5.1    Financial Analysis
        11.5.2    Product Portfolio
        11.5.3    Demographic Reach and Achievements
        11.5.4    Mergers and Acquisitions
        11.5.5    Certifications
    11.6    Koninklijke Philips NV
        11.6.1    Financial Analysis
        11.6.2    Product Portfolio
        11.6.3    Demographic Reach and Achievements
        11.6.4    Mergers and Acquisitions
        11.6.5    Certifications
    11.7    Mindray Medical International Limited
        11.7.1    Financial Analysis
        11.7.2    Product Portfolio
        11.7.3    Demographic Reach and Achievements
        11.7.4    Mergers and Acquisitions
        11.7.5    Certifications
    11.8    Samsung Electronics Co. Ltd.
        11.8.1    Financial Analysis
        11.8.2    Product Portfolio
        11.8.3    Demographic Reach and Achievements
        11.8.4    Mergers and Acquisitions
        11.8.5    Certifications
    11.9    Esaote SPA
        11.9.1    Financial Analysis
        11.9.2    Product Portfolio
        11.9.3    Demographic Reach and Achievements
        11.9.4    Mergers and Acquisitions
        11.9.5    Certifications
    11.10    Siemens Healthineers AG
        11.10.1    Financial Analysis
        11.10.2    Product Portfolio
        11.10.3    Demographic Reach and Achievements
        11.10.4    Mergers and Acquisitions
        11.10.5    Certifications
    11.11    ALPINION MEDICAL SYSTEMS Co., Ltd.
        11.11.1    Financial Analysis
        11.11.2    Product Portfolio
        11.11.3    Demographic Reach and Achievements
        11.11.4    Mergers and Acquisitions
        11.11.5    Certifications
    11.12    CHISON Medical Technologies Co., Ltd.
        11.12.1    Financial Analysis
        11.12.2    Product Portfolio
        11.12.3    Demographic Reach and Achievements
        11.12.4    Mergers and Acquisitions
        11.12.5    Certifications
    11.13    SAMSUNG HEALTHCARE
        11.13.1    Financial Analysis
        11.13.2    Product Portfolio
        11.13.3    Demographic Reach and Achievements
        11.13.4    Mergers and Acquisitions
        11.13.5    Certifications
    11.14    Analogic Corporation
        11.14.1    Financial Analysis
        11.14.2    Product Portfolio
        11.14.3    Demographic Reach and Achievements
        11.14.4    Mergers and Acquisitions
        11.14.5    Certifications
    11.15    General Electric
        11.15.1    Financial Analysis
        11.15.2    Product Portfolio
        11.15.3    Demographic Reach and Achievements
        11.15.4    Mergers and Acquisitions
        11.15.5    Certifications
12    Australia and New Zealand Ultrasound Devices Market - Distribution Model (Additional Insight)
    12.1    Overview 
    12.2    Potential Distributors 
    12.3    Key Parameters for Distribution Partner Assessment 
13    Key Opinion Leaders (KOL) Insights (Additional Insight)
14    Company Competitiveness Analysis (Additional Insight)

    14.1    Very Small Companies
    14.2    Small Companies
    14.3    Mid-Sized Companies
    14.4    Large Companies
    14.5    Very Large Companies
15    Payment Methods (Additional Insight)
    15.1    Government Funded
    15.2    Private Insurance
    15.3    Out-of-Pocket
    

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 6.07% during the forecast period of 2024-2032.

The market demand is driven by the increasing burden of chronic diseases such as cardiovascular diseases and cancer, coupled with the rising healthcare investment in the country and technological advancements.

The current market trend involves the rising support from the government in the form of initiatives and investments in ultrasound devices.

It is commonly divided into stationary ultrasound and portable ultrasound.

Treatment types include advanced 2D ultrasound imaging, 3D and 4D ultrasound imaging, doppler imaging, and high-intensity focused ultrasoundand.

Major applications are anesthesiology, cardiology, gynecology/obstetrics, musculoskeletal, radiology, primary care, critical care, and emergency medicine.

The segments can be divided into handheld, compact, and cart/trolley.

Major end users include hospitals, imaging centres, and research centres.

The key players in the market include Canon Medical Systems Corporation, SonoScape Medical Corp, Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, Mindray Medical International Limited, Samsung Electronics Co. Ltd., Esaote SPA, Siemens Healthineers AG, ALPINION MEDICAL SYSTEMS Co., Ltd., CHISON Medical Technologies Co., Ltd., SAMSUNG HEALTHCARE, Analogic Corporation, and General Electric.

Purchase Full Report

Mini Report

$ 2199     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3299     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4399     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5499     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER